Banque Pictet & Cie’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80.5M | Buy |
67,095
+2,741
| +4% | +$2.8M | 0.5% | 31 |
|
|
2026
Q1 | $59.2M | Sell |
64,354
-8,483
| -12% | -$8.6M | 0.42% | 31 |
|
|
2025
Q4 | $78.3M | Sell |
72,837
-6,902
| -9% | -$6.6M | 0.46% | 25 |
|
|
2025
Q3 | $60.8M | Sell |
79,739
-3,253
| -4% | -$2.42M | 0.35% | 31 |
|
|
2025
Q2 | $64.7M | Sell |
82,992
-5,290
| -6% | -$4.11M | 0.45% | 31 |
|
|
2025
Q1 | $72.9M | Buy |
88,282
+6,301
| +8% | +$5.24M | 0.59% | 26 |
|
|
2024
Q4 | $63.3M | Buy |
81,981
+15,017
| +22% | +$12.4M | 0.42% | 29 |
|
|
2024
Q3 | $59.3M | Buy |
66,964
+2,390
| +4% | +$2.15M | 0.45% | 33 |
|
|
2024
Q2 | $58.5M | Buy |
64,574
+1,735
| +3% | +$1.39M | 0.53% | 31 |
|
|
2024
Q1 | $48.9M | Sell |
62,839
-2,119
| -3% | -$1.51M | 0.46% | 35 |
|
|
2023
Q4 | $37.9M | Sell |
64,958
-54,286
| -46% | -$31.7M | 0.31% | 41 |
|
|
2023
Q3 | $64M | Sell |
119,244
-8,796
| -7% | -$4.53M | 0.76% | 21 |
|
|
2023
Q2 | $60M | Buy |
128,040
+32,606
| +34% | +$13.7M | 0.53% | 30 |
|
|
2023
Q1 | $32.8M | Buy |
95,434
+47,165
| +98% | +$15.9M | 0.32% | 43 |
|
|
2022
Q4 | $17.7M | Sell |
48,269
-34,517
| -42% | -$12.2M | 0.18% | 70 |
|
|
2022
Q3 | $26.8M | Buy |
82,786
+2,540
| +3% | +$805K | 0.29% | 48 |
|
|
2022
Q2 | $26K | Sell |
80,246
-7,895
| -9% | -$2.37M | 0.26% | 52 |
|
|
2022
Q1 | $25.2M | Buy |
88,141
+39
| +0% | +$10K | 0.19% | 63 |
|
|
2021
Q4 | $24.3M | Buy |
88,102
+43,737
| +99% | +$11.1M | 0.18% | 70 |
|
|
2021
Q3 | $10.3M | Sell |
44,365
-2,798
| -6% | -$691K | 0.11% | 89 |
|
|
2021
Q2 | $10.8M | Buy |
47,163
+31,463
| +200% | +$6.32M | 0.12% | 89 |
|
|
2021
Q1 | $2.93M | Sell |
15,700
-3,000
| -16% | -$587K | 0.04% | 177 |
|
|
2020
Q4 | $3.16M | Sell |
18,700
-900
| -5% | -$134K | 0.04% | 166 |
|
|
2020
Q3 | $2.9M | Hold |
19,600
| – | – | 0.04% | 167 |
|
|
2020
Q2 | $3.22M | Sell |
19,600
-2,000
| -9% | -$307K | 0.05% | 159 |
|
|
2020
Q1 | $3M | Sell |
21,600
-750
| -3% | -$103K | 0.06% | 155 |
|
|
2019
Q4 | $2.94M | Buy |
22,350
+1,350
| +6% | +$156K | 0.05% | 185 |
|
|
2019
Q3 | $2.35M | Hold |
21,000
| – | – | 0.04% | 180 |
|
|
2019
Q2 | $2.33M | Sell |
21,000
-20,200
| -49% | -$2.38M | 0.04% | 175 |
|
|
2019
Q1 | $5.35M | Sell |
41,200
-5,000
| -11% | -$608K | 0.1% | 133 |
|
|
2018
Q4 | $5.35M | Sell |
46,200
-2,125
| -4% | -$237K | 0.11% | 129 |
|
|
2018
Q3 | $5.19M | Sell |
48,325
-43,575
| -47% | -$4.36M | 0.1% | 140 |
|
|
2018
Q2 | $7.84M | Sell |
91,900
-40,472
| -31% | -$3.32M | 0.15% | 104 |
|
|
2018
Q1 | $10.2M | Sell |
132,372
-4,250
| -3% | -$342K | 0.22% | 79 |
|
|
2017
Q4 | $11.5M | Sell |
136,622
-7,331
| -5% | -$624K | 0.23% | 64 |
|
|
2017
Q3 | $12.3M | Buy |
143,953
+19,293
| +15% | +$1.58M | 0.28% | 66 |
|
|
2017
Q2 | $10.3M | Sell |
124,660
-5,098
| -4% | -$416K | 0.24% | 74 |
|
|
2017
Q1 | $10.9M | Sell |
129,758
-22,325
| -15% | -$1.79M | 0.27% | 70 |
|
|
2016
Q4 | $11.2M | Buy |
152,083
+4,019
| +3% | +$299K | 0.29% | 68 |
|
|
2016
Q3 | $11.9M | Buy |
148,064
+112,064
| +311% | +$8.97M | 0.31% | 64 |
|
|
2016
Q2 | $2.83M | Buy |
+36,000
| New | +$2.71M | 0.08% | 150 |
|
|
2014
Q1 | – | Sell |
-46,500
| Closed | -$2.37M | – | 443 |
|
|
2013
Q4 | $2.37M | Buy |
+46,500
| New | +$2.33M | 0.07% | 166 |
|
Other funds holding LLY
Banque Pictet & Cie's LLY Position: Q2 2026 in Review
Banque Pictet & Cie increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $2.8M and bringing the position to 67,095 shares worth $80.5M. The position accounts for 0.5% of the portfolio, ranked #31.
Banque Pictet & Cie first reported a position in LLY in Q4 2013 and has held it in 42 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Banque Pictet & Cie held 67,095 shares of Eli Lilly worth $80.5M as of Q2 2026.
- Banque Pictet & Cie bought 2,741 Eli Lilly shares in Q2 2026, an estimated $2.8M.
- Eli Lilly made up 0.5% of Banque Pictet & Cie's portfolio in Q2 2026, its #31 holding.
- Banque Pictet & Cie first reported a position in Eli Lilly in Q4 2013 and has held it in 42 quarters since.
- 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.